Senior insider sale
President & CEO at VIKING THERAPEUTICS, INC. — senior position signals high conviction
$9.06M
272.40K shares
What this filing means
LIAN BRIAN plans to sell 272.40K shares of VIKING THERAPEUTICS, INC. valued at approximately $9.06M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/5/2026ACC: 0001950047-26-000104
DirectorOfficer· President & CEO
Since Jan 2019
272.40K
Shares to sell
$9.06M
Approx. market value
233.41K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months3
Restricted stock vesting under a registered plan
Cash
1/3/2026
101.74KPerformance Stock Units
Cash
1/2/2026
130.25KPerformance Stock Units
Cash
1/2/2026
1.42KTotal acquired233.41K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/3/2026 | Restricted stock vesting under a registered plan Cash | 101.74K | — |
1/2/2026 | Performance Stock Units Cash | 130.25K | — |
1/2/2026 | Performance Stock Units Cash | 1.42K | — |
| Total | 233.41K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
38.99K
Market value
$1.36M
10/28/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
233.41K
Market value
$7.69M
1/5/2026
Total
Units
272.40K
Value
$9.06M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
10/28/2025 | 38.99K | $1.36M | — | Completed |
| Planned — Approximate Date | ||||
1/5/2026 | 233.41K | $7.69M | NASDAQ | Planned |
| Total | 272.40K | $9.06M | ||